Long‐term outcomes following transplantation of tumourectomised kidneys: a 30‐year experience

Objectives To report the long‐term oncological and graft outcomes of a 30‐year single‐centre experience with transplantation of carefully selected tumourectomised kidneys. Patients and Methods A retrospective single‐centre cohort study was performed of all recipients who underwent kidney transplantation following ex vivo bench excision of electively or incidentally detected kidney tumours ≤3 cm between 1996 and 2026 at the Princess Alexandra Hospital (Brisbane, Australia). Recipient, donor, and tumour characteristics, perioperative outcomes, oncological outcomes, patient survival and graft survival were evaluated. Results A total of 64 recipients underwent kidney transplantation following ex vivo bench excision of a small kidney mass during the study period, with a median (interquartile range [IQR]) follow‐up of 11.3 (6.9–15.8) years. The median (IQR) recipient age was 62.5 (54.7–68.6) years. Most donor tumours were small, organ‐confined renal cell carcinomas (RCC) with negative surgical margins following bench excision. Three presumed tumour recurrences occurred during follow‐up (5.0%), comprising one local recurrence at the previous tumour excision site and two presumed de novo allograft tumours, with no metastatic disease or cancer‐specific mortality. At latest follow‐up, 50 recipients had died, including 34 (68.0%) with a functioning graft. Estimated patient survival was 93.5%, 88.7% and 62.9% at 1, 5 and 10 years respectively, with acceptable long‐term graft outcomes. Conclusions Transplantation of carefully selected tumourectomised kidneys provides long‐term oncological safety and acceptable patient and graft outcomes. These findings support the continued consideration of tumourectomised kidneys from living and deceased donors as a safe and effective strategy to expand the donor pool, reduce organ discard and increase access to kidney transplantation.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2026-11-19
DOI
https://doi.org/10.1111/bju.70555
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long‐term outcomes following transplantation of tumourectomised kidneys: a 30‐year experience

Handoo Rhee, Ai Lin Tan, David Wayne Johnson, Ryan Gately et al.
British Journal of Urology
Renal Transplantation Outcomes and Treatments
article

Long‐term outcomes following transplantation of tumourectomised kidneys: a 30‐year experience

Handoo Rhee, Ai Lin Tan, David Wayne Johnson, Ryan Gately, Nicole M. Isbel, Scott B. Campbell, John Preston, David L. Nicol, Anthony Griffin, Rachel Cockburn, Simon Wood, Malcolm Lawson, Michael Keys, Vijay Kanagarjah
article en

Abstract

Objectives To report the long‐term oncological and graft outcomes of a 30‐year single‐centre experience with transplantation of carefully selected tumourectomised kidneys. Patients and Methods A retrospective single‐centre cohort study was performed of all recipients who underwent kidney transplantation following ex vivo bench excision of electively or incidentally detected kidney tumours ≤3 cm between 1996 and 2026 at the Princess Alexandra Hospital (Brisbane, Australia). Recipient, donor, and tumour characteristics, perioperative outcomes, oncological outcomes, patient survival and graft survival were evaluated. Results A total of 64 recipients underwent kidney transplantation following ex vivo bench excision of a small kidney mass during the study period, with a median (interquartile range [IQR]) follow‐up of 11.3 (6.9–15.8) years. The median (IQR) recipient age was 62.5 (54.7–68.6) years. Most donor tumours were small, organ‐confined renal cell carcinomas (RCC) with negative surgical margins following bench excision. Three presumed tumour recurrences occurred during follow‐up (5.0%), comprising one local recurrence at the previous tumour excision site and two presumed de novo allograft tumours, with no metastatic disease or cancer‐specific mortality. At latest follow‐up, 50 recipients had died, including 34 (68.0%) with a functioning graft. Estimated patient survival was 93.5%, 88.7% and 62.9% at 1, 5 and 10 years respectively, with acceptable long‐term graft outcomes. Conclusions Transplantation of carefully selected tumourectomised kidneys provides long‐term oncological safety and acceptable patient and graft outcomes. These findings support the continued consideration of tumourectomised kidneys from living and deceased donors as a safe and effective strategy to expand the donor pool, reduce organ discard and increase access to kidney transplantation.

British Journal of Urology
Translational Research Institute (AU), Royal Marsden NHS Foundation Trust (GB), The University of Queensland (AU), Princess Alexandra Hospital (AU), Metro South Health (AU), Royal Marsden Hospital (GB)
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon